Compare BDX & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BDX | IDXX |
|---|---|---|
| Founded | 1897 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.5B | 55.0B |
| IPO Year | 1962 | 1991 |
| Metric | BDX | IDXX |
|---|---|---|
| Price | $202.41 | $722.22 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 10 |
| Target Price | $205.25 | ★ $700.50 |
| AVG Volume (30 Days) | ★ 1.9M | 511.9K |
| Earning Date | 02-04-2026 | 02-02-2026 |
| Dividend Yield | ★ 2.07% | N/A |
| EPS Growth | N/A | ★ 21.65 |
| EPS | 5.82 | ★ 12.60 |
| Revenue | ★ $21,840,000,000.00 | $4,167,411,000.00 |
| Revenue This Year | $4.02 | $12.15 |
| Revenue Next Year | $3.37 | $8.72 |
| P/E Ratio | ★ $34.84 | $56.61 |
| Revenue Growth | 8.24 | ★ 8.39 |
| 52 Week Low | $162.29 | $356.14 |
| 52 Week High | $251.99 | $769.98 |
| Indicator | BDX | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 59.60 | 61.20 |
| Support Level | $201.29 | $694.52 |
| Resistance Level | $206.99 | $724.99 |
| Average True Range (ATR) | 3.52 | 15.10 |
| MACD | 0.53 | 3.67 |
| Stochastic Oscillator | 68.44 | 95.61 |
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of 2024 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.